Back

Introduction.

22 May 2016 (10:15 - 10:20)
Organised by:
Congress Presentation Part of: Novel strategies for addressing diabetes & heart failure: evaluating cardiovascular outcomes Chronic heart failure HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Professor Stefan Anker

Charite University Hospital, Berlin (Germany)

2 More presentations in this session

Presentation thumbnail
Cardiovascular outcomes of SGLT2 inhibition: evidence from recent clinical trials.
Doctor D. Fitchett (Toronto, CA)
Presentation thumbnail
Interactive case discussion: what are the clinical implications of cardiovascular outcomes of SGLT2 inhibition?
Professor S. Anker (Berlin, DE) Doctor D. Fitchett (Toronto, CA)

Access the full session

Session thumbnail
Novel strategies for addressing diabetes & heart failure: evaluating cardiovascular outcomes

The Event

Event poster

HEART FAILURE 2016

22 May 2016 10:15 CET
You may be interested in
thumbnail
Congress Session
What about acute care in the new ESC Guidelines?
25 March 2023
thumbnail
Congress Presentation
The experience of cardiovascular professional training across europe: preliminary results from the ESC young cardiovascular professionals survey
27 August 2021
thumbnail
Congress Presentation
Rationale and design of the CADENCE trial: evaluating sotatercept in Cpc-PH secondary to HFpEF
1 September 2025
thumbnail
Congress Presentation
Continuing education curriculum improved cardiologists knowledge, competence and confidence on treatment of heart failure with preserved ejection fraction
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources